Home > Insider Trading > Filing (0001493152-23-031869)

Filing Details

Accession Number:: 0001493152-23-031869
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-09-06 17:17:17
Reporting Period:: 2023-07-18

Accepted Time:: 2023-09-06 17:17:17
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1886799	Bright Green Corp	BGXX	Medicinal Chemicals & Botanical Products (2833)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1927032	Lynn Stockwell	1033 George Hanosh Boulevard Grants NM 87020		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-07-18	2,500,000	$0.00	67,583,475	No	4	G	Direct
Common Stock	Disposition	2023-08-22	977,777	$0.00	66,605,698	No	4	G	Direct
Common Stock	Disposition	2023-08-31	250,000	$0.47	66,355,698	No	4	S	Direct
Common Stock	Acquisiton	2023-09-01	2,827,960	$1.15	69,183,658	No	4	J	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	G	Direct
No	4	G	Direct
No	4	S	Direct
No	4	J	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Acquisiton	2023-09-01	2,827,960	$0.13	2,827,960	$3.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,827,960	2023-09-01		No	4	J	Direct

Footnotes

These transactions involved a bona fide gift of securities by the Reporting Person's child to the Reporting Person and subsequent bona fide gift of securities by the Reporting Person to family members of the Report Person. No consideration was paid by or to the Reporting Person in connection with these transactions.
This transaction involved an open market sale of the Issuer's Common Stock. Reflects the weighted average price of 250,000 shares of common stock of the Issuer sold by the Reporting Person in multiple transactions on August 31, 2023, with sales prices ranging from $0.4549 to $0.4823 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
In connection with an unsecured line of credit in the form of a note (the "Note") between the Issuer and the Reporting Person, on September 1, 2023, the Issuer and the Reporting Person entered into an agreement pursuant to which the Issuer issued to the Reporting Person (i) 2,827,960 shares (the "Shares") of the Issuer's common stock at a conversion price of $1.15 per share, and (ii) warrants (the "Warrants") to purchase up to 2,827,960 shares of the Issuer's common stock at a conversion price of $0.13 per warrant. The issuance of the Shares and the Warrants was made to settle all amounts of principal interests and other costs under the Note as of August 31, 2023 (the "Repayment Obligation").
The Warrants are exercisable immediately upon issuance at an exercise price of $3.00 per share, and shall expire on the earlier of (i) the date that is 45 days after the closing price of the Common Stock on the Nasdaq Capital Market equals or exceeds $3.00 per share, and (ii) August 31, 2024.